FIELD: biochemistry.
SUBSTANCE: present invention relates to compounds of Formula (I) and to pharmaceutical compositions containing them:
wherein the values of substituents are indicated in the claims. Such compounds for use in the treatment of cancer and other diseases associated with altered angiogenesis, such as pathologies related to arthritis, diabetic retinopathy, psoriasis and chronic inflammatory disease, are also included in the scope of the present invention.
EFFECT: invention can be used in treatment of cancer and other diseases associated with altered angiogenesis, such as pathologies related to arthritis, diabetic retinopathy, psoriasis and chronic inflammatory disease.
10 cl, 11 tbl, 1 dwg, 23 ex
Title | Year | Author | Number |
---|---|---|---|
MODULATORS OF ATP-BINDING TRANSPORTERS | 2010 |
|
RU2552353C2 |
MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTERS | 2005 |
|
RU2528046C2 |
ATP-BINDING CASETTE TRANSPORTER MODULATORS | 2005 |
|
RU2382779C2 |
METHOD OF MODULATING TRANSPORTERS OF ATP-BINDING CASSETTE | 2005 |
|
RU2525115C2 |
MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2005 |
|
RU2556984C2 |
SPIRO- OR DISPIRO-1,2,4-TRIOXOLANE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT | 2002 |
|
RU2271357C2 |
SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS, METHODS OF PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE AGENT | 2014 |
|
RU2654483C2 |
METHOD FOR TREATMENT OF ALLERGY BY USING SUBSTITUTED PYRAZOLES | 2001 |
|
RU2290179C2 |
METHOD FOR TREATMENT ALLERGY BY USING SUBSTITUTED PYRAZOLES | 2001 |
|
RU2277909C2 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
Authors
Dates
2021-05-31—Published
2017-09-28—Filed